NCT00001462View on ClinicalTrials.gov

Characterization of the Pathobiology of Early Lung Destruction in Alpha 1-Antitrypsin Deficient Individuals

CompletedOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

May 31, 1995

Study Completion Date

April 30, 2000

Conditions
EmphysemaLung Diseases, ObstructiveAlpha 1-Antitrypsin Deficiency
Trial Locations (1)

20892

National Heart, Lung and Blood Institute (NHLBI), Bethesda

All Listed Sponsors
lead

National Heart, Lung, and Blood Institute (NHLBI)

NIH

NCT00001462 - Characterization of the Pathobiology of Early Lung Destruction in Alpha 1-Antitrypsin Deficient Individuals | Biotech Hunter | Biotech Hunter